54 Participants Needed

Warm Humidified CO2 Insufflation for Gastric Bypass Surgery

EB
AR
Overseen ByAngielyn Rivera
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: The University of Texas Health Science Center, Houston
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 3 JurisdictionsThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

The purpose of this study is to To determine the effect of warm and humidified (WH) carbon dioxide (CO2) on post-operative pain/analgesia requirement in patients undergoing laparoscopic bariatric surgery.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are taking daily pain medications (narcotics) or steroids.

What data supports the effectiveness of the treatment Warm Humidified CO2 Insufflation for Gastric Bypass Surgery?

Research suggests that using warm humidified carbon dioxide (CO2) during laparoscopic gastric bypass surgery can reduce postoperative pain and the need for pain medication, as well as shorten recovery time compared to using cold dry CO2. This is because the warm humidified CO2 helps prevent hypothermia (abnormally low body temperature) and drying out of cells in the abdomen.12345

Is warm humidified CO2 insufflation safe for use in gastric bypass surgery?

Research indicates that using warm humidified CO2 during laparoscopic gastric bypass surgery is generally safe and may reduce postoperative pain and recovery time compared to cold dry CO2. However, it may increase the cost of the procedure.13678

What makes warm humidified CO2 insufflation unique in gastric bypass surgery?

Warm humidified CO2 insufflation during gastric bypass surgery is unique because it uses heated and humidified gas instead of cold, dry gas, which can reduce postoperative pain, hypothermia, and recovery time compared to traditional methods.124910

Research Team

Erik B. Wilson | UT Physicians ...

Erik B Wilson, MD

Principal Investigator

The University of Texas Health Science Center, Houston

Eligibility Criteria

This trial is for patients scheduled for elective bariatric surgery, including primary or revision procedures and hiatal hernia repairs. It's not specified who can't join the trial.

Inclusion Criteria

elective bariatric primary or revision procedures and hiatal hernia repair procedures for all indications.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo laparoscopic bariatric surgery using either warm humidified CO2 or dry CO2

1 day
1 visit (in-person)

Postoperative Care

Participants are monitored in the Post Anesthesia Care Unit (PACU) for analgesic requirements and temperature

Several hours
1 visit (in-person)

Follow-up

Participants are monitored for pain and analgesia requirements post-surgery

24 hours

Treatment Details

Interventions

  • Dry CO2
  • Minimally Invasive Bariatric (Gastric Bypass) Surgery
  • Warm humidified CO2
Trial OverviewThe study compares two methods of insufflation (pumping gas to expand the abdomen) during laparoscopic bariatric surgery: one uses dry CO2, and the other uses warm humidified CO2. The goal is to see if warm humidified CO2 reduces post-operative pain and need for painkillers.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Warm humidified CO2Experimental Treatment1 Intervention
Group II: Dry CO2Active Control1 Intervention

Minimally Invasive Bariatric (Gastric Bypass) Surgery is already approved in European Union, United States, Canada for the following indications:

🇪🇺
Approved in European Union as Laparoscopic Gastric Bypass Surgery for:
  • Obesity
  • Type 2 Diabetes Mellitus
  • Gastroesophageal Reflux Disease
🇺🇸
Approved in United States as Laparoscopic Gastric Bypass Surgery for:
  • Obesity
  • Type 2 Diabetes Mellitus
  • Gastroesophageal Reflux Disease
  • Sleep Apnea
🇨🇦
Approved in Canada as Laparoscopic Gastric Bypass Surgery for:
  • Obesity
  • Type 2 Diabetes Mellitus
  • Gastroesophageal Reflux Disease

Find a Clinic Near You

Who Is Running the Clinical Trial?

The University of Texas Health Science Center, Houston

Lead Sponsor

Trials
974
Recruited
361,000+

Findings from Research

In a study of 50 patients undergoing laparoscopic gastric bypass, heated-humidified carbon dioxide insufflation led to significantly less shoulder pain at 18 hours post-surgery compared to cold-dry insufflation.
However, there were no significant differences in abdominal pain, overall narcotic use, or length of hospital stay between the two groups, indicating that while heated-humidified gas may help with shoulder pain, it does not provide major benefits in other areas.
Prospective randomized trial of heated humidified versus cold dry carbon dioxide insufflation during laparoscopic gastric bypass.Champion, JK., Williams, M.[2013]
In a study of 30 patients undergoing laparoscopic Roux-en-Y gastric bypass, using warmed and humidified CO2 for insufflation did not significantly reduce postoperative pain or narcotic usage compared to standard dry CO2.
However, the warmed and humidified CO2 group experienced shorter operating room times (76 vs 101 minutes) and reduced hospital stays (3.2 vs 4.0 days), indicating potential logistical benefits without impacting pain management.
Beneficial effects of humidified, warmed carbon dioxide insufflation during laparoscopic bariatric surgery: a randomized clinical trial.Savel, RH., Balasubramanya, S., Lasheen, S., et al.[2017]
Using helium instead of carbon dioxide for insufflation during laparoscopic gastric bypass surgery resulted in significantly lower levels of carbon dioxide (pCO2) and higher pH levels in a study involving 5 Yorkshire swine.
Helium insufflation allowed for a quicker normalization of pCO2 levels after surgery, suggesting it may reduce the risk of hypercarbia and acidosis compared to traditional CO2 insufflation, indicating potential benefits for morbidly obese patients undergoing this procedure.
Helium pneumoperitoneum ameliorates hypercarbia and acidosis associated with carbon dioxide insufflation during laparoscopic gastric bypass in pigs.Brackman, MR., Finelli, FC., Light, T., et al.[2013]

References

Prospective randomized trial of heated humidified versus cold dry carbon dioxide insufflation during laparoscopic gastric bypass. [2013]
Beneficial effects of humidified, warmed carbon dioxide insufflation during laparoscopic bariatric surgery: a randomized clinical trial. [2017]
Helium pneumoperitoneum ameliorates hypercarbia and acidosis associated with carbon dioxide insufflation during laparoscopic gastric bypass in pigs. [2013]
An assessment by calorimetric calculations of the potential thermal benefit of warming and humidification of insufflated carbon dioxide. [2014]
High flow insufflation for the maintenance of the pneumoperitoneum during bariatric surgery. [2021]
Laparoscopic gastric bypass for refractory morbid obesity. [2005]
Perforated gastric ulcer post mini gastric bypass treated by laparoscopy: A case report. [2022]
Gastric bypass. [2019]
Impact of temperature and humidity of carbon dioxide pneumoperitoneum on body temperature and peritoneal morphology. [2019]
Warmed and humidified carbon dioxide for abdominal laparoscopic surgery: meta-analysis of the current literature. [2018]